We are live on ! Find out more
GC

Gratus Capital Portfolio holdings

AUM $2.5B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
AUM
$700M
AUM Growth
+$5.58M
Cap. Flow
-$15.5M
Cap. Flow %
-2.22%
Top 10 Hldgs %
43.97%
Holding
187
New
11
Increased
47
Reduced
46
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.09M
2
EW icon
Edwards Lifesciences
EW
+$2.4M
3
SYY icon
Sysco
SYY
+$1.88M
4
INTC icon
Intel
INTC
+$1.77M
5
UHAL icon
U-Haul Holding Co
UHAL
+$1.26M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.15%
2 Industrials 11.32%
3 Healthcare 10.36%
4 Financials 9.23%
5 Technology 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNS icon
76
Scotiabank
BNS
$106B
$2.11M 0.3%
35,125
-75
-0.2% -$4.3K
WTM icon
77
White Mountains Insurance
WTM
$5.47B
$2.11M 0.3%
2,427
JCI icon
78
Johnson Controls International
JCI
$87.5B
$2.1M 0.3%
48,442
TXN icon
79
Texas Instruments
TXN
$255B
$2.06M 0.29%
26,713
-707
-3% -$56.7K
GOOGL icon
80
Alphabet (Google) Class A
GOOGL
$3.91T
$2.01M 0.29%
43,240
EGP icon
81
EastGroup Properties
EGP
$11.5B
$1.91M 0.27%
22,770
SYY icon
82
Sysco
SYY
$39.7B
$1.77M 0.25%
+35,170
New +$1.88M
STI
83
DELISTED
SunTrust Banks, Inc.
STI
$1.77M 0.25%
31,210
-1,000
-3% -$55.6K
CAH icon
84
Cardinal Health
CAH
$53.4B
$1.74M 0.25%
22,337
BBBY
85
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.7M 0.24%
56,010
AAP icon
86
Advance Auto Parts
AAP
$3.37B
$1.7M 0.24%
14,578
+452
+3% +$62.1K
GSK icon
87
GSK
GSK
$103B
$1.63M 0.23%
30,266
-752
-2% -$40.1K
PFE icon
88
Pfizer
PFE
$140B
$1.5M 0.21%
47,155
-320
-0.7% -$10.1K
CVX icon
89
Chevron
CVX
$388B
$1.5M 0.21%
14,329
+2
+0% +$212
RES icon
90
RPC Inc
RES
$1.24B
$1.46M 0.21%
72,385
AMGN icon
91
Amgen
AMGN
$203B
$1.46M 0.21%
8,465
-28,079
-77% -$4.57M
PM icon
92
Philip Morris
PM
$301B
$1.37M 0.2%
11,673
+6
+0.1% +$695
MTB icon
93
M&T Bank
MTB
$36.2B
$1.35M 0.19%
8,359
ADP icon
94
Automatic Data Processing
ADP
$100B
$1.35M 0.19%
13,184
NVO
95
Novo Nordisk
NVO
$216B
$1.33M 0.19%
62,000
MO icon
96
Altria Group
MO
$122B
$1.31M 0.19%
17,663
+816
+5% +$59.7K
KMB icon
97
Kimberly-Clark
KMB
$36.4B
$1.29M 0.18%
9,994
-53
-0.5% -$6.9K
UHAL icon
98
U-Haul Holding Co
UHAL
$14B
$1.27M 0.18%
+34,700
New +$1.26M
AYI icon
99
Acuity Brands
AYI
$9.88B
$1.25M 0.18%
6,173
RDI icon
100
Reading International Class A
RDI
$32.9M
$1.25M 0.18%
77,340
+6,755
+10% +$105K

Similar funds

Gratus Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Gratus Capital held 187 positions worth $700M, up 0.8% from $695M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Gratus Capital's Q2 2017 filing shows 11 new, 47 increased, 46 reduced and 3 closed positions. Its largest new stake was AbbVie: 75,718 shares worth $5.49M. The largest sale was Schwab US REIT ETF, an estimated $8.43M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.

  • Gratus Capital's largest Q2 2017 buy was AbbVie: 75,718 shares worth $5.49M.
  • Gratus Capital added most to Intel in Q2 2017, an estimated $1.77M increase.
  • Gratus Capital's biggest Q2 2017 reduction was Schwab US REIT ETF, cutting an estimated $8.43M.
  • Gratus Capital fully exited Valspar in Q2 2017, selling an estimated $8.19M.
  • Gratus Capital's ten largest holdings make up 44% of its $700M portfolio in Q2 2017.
  • Gratus Capital opened 11 new positions and closed 3 in Q2 2017.
  • Gratus Capital's portfolio value rose 0.8% quarter-over-quarter to $700M.

Based on Gratus Capital's 13F filing for Q2 2017, filed 8 Aug 2017.